DDL-218

Overview

DDL-218 is an orally active and potent SirT1 inhibitor. DDL-218 enhances SirT1 in ApoE4-expressing neurons and a murine AD model. DDL-218 can be used in the study of Alzheimer's disease.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Sirtuin

Product Information

• Catalog No.: HY-176434
• CAS No.: 2767324-34-3
• Molecular Formula: C12H18N2O2
• Molecular Weight: 222.28
• Purity: 99.49%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 5 mg/mL (22.49 mM); Clear solution
• Availability: In-stock

Source

Original product source